Skip to the content
REVOLUTIONIZING TREATMENT DECISIONS
Follow us on
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Press Releases
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Request a demo
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Press Releases
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Blogs
▶
Podcast
Generalized Pairwise Comparisons (GPC): An innovative statistical methodology.
Back
Read also
Blogs
Net Treatment Benefit in rare disease trials: Aligning trial design with clinically meaningful outcomes
READ MORE
→
Blogs
A Practical Guide to Patient-Centric Trials Using Net Treatment Benefit
READ MORE
→
Innovative Trial Design
OSE Immunotherapeutics and One2Treat jointly won the Innovation award for Endpoint Design in the 2025 Clinical Trials Arena Excellence Awards
READ MORE
→
Blogs
Reactions to Being “Powered By Purpose” on Clinical Trials Day 2025
READ MORE
→
Want to invest in a more holistic understanding
of net treatment benefit?
Get in touch